FDA Approved: RECLAST — Original Application (Sandoz Inc)

View source ↗

Summary

FDA approves Sandoz's RECLAST (zoledronic acid) original application for osteoporosis-related indications, including postmenopausal osteoporosis, osteoporosis i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glucocorticoid-induced Osteoporosis
• Osteoporosis in Men
• Paget Disease of Bone
• Postmenopausal Osteoporosis

Drugs mentioned

• RECLAST (ZOLEDRONIC ACID)

Snippet

ORIG AP for RECLAST (ZOLEDRONIC ACID)